Roger Stupp
Northwestern University
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Glioma Diagnosis and Treatment
Strong evidence · 7 supporting papers · latest 2026
Cancer Treatment and Pharmacology
Solid evidence · 1 supporting paper · latest 2026
Brain Metastases and Treatment
Solid evidence · 4 supporting papers · latest 2026
Monoclonal and Polyclonal Antibodies Research
Solid evidence · 2 supporting papers · latest 2026
CAR-T cell therapy research
Solid evidence · 3 supporting papers · latest 2026
Ultrasound and Hyperthermia Applications
Solid evidence · 1 supporting paper · latest 2026
Immune cells in cancer
Solid evidence · 2 supporting papers · latest 2026
Immunotherapy and Immune Responses
Solid evidence · 1 supporting paper · latest 2026
Publications (14)
Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU)
2026DOIPMID 42391581
Association between temozolomide-related hematologic toxicity and health-related quality of life (HRQoL) in patients with newly diagnosed glioblastoma
2026DOIPMID 42711275
Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205
2026DOIPMID 42189896
Temozolomide-associated inflammatory-repair remodeling in recurrent glioblastoma exposes a ROCK-linked therapeutic vulnerability
2026DOI
The perinecrotic niche of glioblastoma drives tumor-associated macrophage polarization and immunosuppression via podoplanin-mediated CLEC5A activation
2026DOIPMID 42228429
A phase I, dose-escalation study of weekly vinflunine in patients with advanced solid tumours
2026DOI
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
2026DOI
Fully Humanized Bispecific T Cell Engager Shows Potent Activity in Central Nervous System and Peripheral Tumors
2026DOIPMID 42057694
Ultrasound-mediated blood–brain barrier modulation enhances T-cell access but requires immune activation for effective CNS immunity
2026DOIPMID 42718384
Abstract 4386: Expanding the therapeutic potential of Bvax: A B-cell-based vaccine for solid tumors
2026DOI
Abstract No. 220 EMBARGO ▪ FEATURED ABSTRACT Y90 Radioembolization Planning for Recurrent Glioblastoma: Angiographic Analysis
2026DOI
Supplementary Figures1 from Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205
2026DOI
O-023 Intra-arterial delivery of yttrium-90 glass microspheres in recurrent glioblastoma: technical, safety, and early clinical results from patients treated in the FRONTIER trial
2026DOI
Supplementary Tables1 from Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205
2026DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Northwestern University
Source: OpenAlex · retrieved 2026-09-29